These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 16540899

  • 1. Nasal vaccination with CpG oligodeoxynucleotide induces protective immunity against non-typeable Haemophilus influenzae in the nasopharynx.
    Abe N, Kodama S, Hirano T, Eto M, Suzuki M.
    Laryngoscope; 2006 Mar; 116(3):407-12. PubMed ID: 16540899
    [Abstract] [Full Text] [Related]

  • 2. Local application of CpG oligodeoxynucleotide enhances nontypeable Haemophilus influenzae-specific mucosal IgA responses in the middle ear.
    Kodama S, Hirano T, Abe N, Suzuki M.
    Acta Otolaryngol; 2007 Aug; 127(8):809-15. PubMed ID: 17762989
    [Abstract] [Full Text] [Related]

  • 3. Nasal immunization with plasmid DNA encoding P6 protein and immunostimulatory complexes elicits nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.
    Kodama S, Hirano T, Noda K, Umemoto S, Suzuki M.
    Vaccine; 2011 Feb 24; 29(10):1881-90. PubMed ID: 21237276
    [Abstract] [Full Text] [Related]

  • 4. A single nasal dose of fms-like tyrosine kinase receptor-3 ligand, but not peritoneal application, enhances nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.
    Kodama S, Hirano T, Noda K, Abe N, Suzuki M.
    Vaccine; 2010 Mar 16; 28(13):2510-6. PubMed ID: 20117272
    [Abstract] [Full Text] [Related]

  • 5. Th17 cells contribute to nontypeable Haemophilus influenzae-specific protective immunity induced by nasal vaccination with P6 outer membrane protein and α-galactosylceramide.
    Noda K, Kodama S, Umemoto S, Nomi N, Hirano T, Suzuki M.
    Microbiol Immunol; 2011 Aug 16; 55(8):574-81. PubMed ID: 21605159
    [Abstract] [Full Text] [Related]

  • 6. Safety and efficacy of nasal application of CpG oligodeoxynucleotide as a mucosal adjuvant.
    Kodama S, Abe N, Hirano T, Suzuki M.
    Laryngoscope; 2006 Feb 16; 116(2):331-5. PubMed ID: 16467729
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Nasal-associated lymphoid tissue immunity and vaccine development.
    Kodama S, Suzuki M.
    Adv Otorhinolaryngol; 2011 Feb 16; 72():110-2. PubMed ID: 21865705
    [Abstract] [Full Text] [Related]

  • 9. A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.
    Hotomi M, Ikeda Y, Suzumoto M, Yamauchi K, Green BA, Zlotnick G, Billal DS, Shimada J, Fujihara K, Yamanaka N.
    Vaccine; 2005 Jan 26; 23(10):1294-300. PubMed ID: 15652672
    [Abstract] [Full Text] [Related]

  • 10. A single nasal dose of CCL20 chemokine induces dendritic cell recruitment and enhances nontypable Haemophilus influenzae-specific immune responses in the nasal mucosa.
    Kodama S, Abe N, Hirano T, Suzuki M.
    Acta Otolaryngol; 2011 Sep 26; 131(9):989-96. PubMed ID: 21534717
    [Abstract] [Full Text] [Related]

  • 11. Nasal immunization induces Haemophilus influenzae-specific Th1 and Th2 responses with mucosal IgA and systemic IgG antibodies for protective immunity.
    Kurono Y, Yamamoto M, Fujihashi K, Kodama S, Suzuki M, Mogi G, McGhee JR, Kiyono H.
    J Infect Dis; 1999 Jul 26; 180(1):122-32. PubMed ID: 10353870
    [Abstract] [Full Text] [Related]

  • 12. Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529.
    Mason KW, Zhu D, Scheuer CA, McMichael JC, Zlotnick GW, Green BA.
    Vaccine; 2004 Sep 03; 22(25-26):3449-56. PubMed ID: 15308371
    [Abstract] [Full Text] [Related]

  • 13. Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae.
    Bertot GM, Becker PD, Guzmán CA, Grinstein S.
    J Infect Dis; 2004 Apr 01; 189(7):1304-12. PubMed ID: 15031801
    [Abstract] [Full Text] [Related]

  • 14. Maternal intranasal immunization with outer membrane protein P6 maintains specific antibody level of derived offspring.
    Yamauchi K, Hotomi M, Billal DS, Suzumoto M, Yamanaka N.
    Vaccine; 2006 Jun 19; 24(25):5294-9. PubMed ID: 16697503
    [Abstract] [Full Text] [Related]

  • 15. Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media.
    Sabirov A, Kodama S, Hirano T, Suzuki M, Mogi G.
    Infect Immun; 2001 May 19; 69(5):2964-71. PubMed ID: 11292713
    [Abstract] [Full Text] [Related]

  • 16. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
    Nyström-Asklin J, Adamsson J, Harandi AM.
    Scand J Immunol; 2008 May 19; 67(5):431-40. PubMed ID: 18298617
    [Abstract] [Full Text] [Related]

  • 17. Neonatal sublingual vaccination with Salmonella proteins and adjuvant cholera toxin or CpG oligodeoxynucleotides induces mucosal and systemic immunity in mice.
    Huang CF, Wang CC, Wu TC, Wu KG, Lee CC, Peng HJ.
    J Pediatr Gastroenterol Nutr; 2008 Mar 19; 46(3):262-71. PubMed ID: 18376242
    [Abstract] [Full Text] [Related]

  • 18. Role of an immunodominant T cell epitope of the P6 protein of nontypeable Haemophilus influenzae in murine protective immunity.
    McMahon M, Murphy TF, Kyd J, Thanavala Y.
    Vaccine; 2005 May 20; 23(27):3590-6. PubMed ID: 15855018
    [Abstract] [Full Text] [Related]

  • 19. Eustachian tube possesses immunological characteristics as a mucosal effector site and responds to P6 outer membrane protein of nontypeable Haemophilus influenzae.
    Kodama S, Hirano T, Suenaga S, Abe N, Suzuki M.
    Vaccine; 2006 Feb 13; 24(7):1016-27. PubMed ID: 16242817
    [Abstract] [Full Text] [Related]

  • 20. Intranasal immunization with outer membrane protein P6 and cholera toxin induces specific sinus mucosal immunity and enhances sinus clearance of nontypeable Haemophilus influenzae.
    Sabirov A, Kodama S, Sabirova N, Mogi G, Suzuki M.
    Vaccine; 2004 Aug 13; 22(23-24):3112-21. PubMed ID: 15297063
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.